Marlborough biotech firm Advanced Cell Technology said it has picked up $30 million in capital through a common stock purchase agreement with a Chicago-based investment firm. The deal, with Lincoln ...

WASHINGTON (KRT) ­ A Massachusetts company said Sunday that it had for the first time cloned an early human embryo in an experiment intended to eventually produce matching cells for patients with a ...

Researchers in the U.S. created monkey embryos asexually, without the use of sperm, in order to harvest stem cells from them. The company behind the research, Advanced Cell Technology, says the ...

LOS ANGELES (Reuters) - Biotechnology company Advanced Cell Technology Inc. plans to publish in the first half of this year data from trials in animals of its stem cell-based therapies for macular ...

WASHINGTON, Nov 22 (Reuters) - Massachusetts-based Advanced Cell Technology said the U.S. Food and Drug Administration approved a clinical trial of its human embryonic stem cell treatment for a ...

Ocata Therapeutics of Marlborough, which researches treatments for eye diseases, has agreed to be sold to Astellas Pharma Inc. of Japan for $379 million, the two companies announced late Monday.

Advanced Cell Technology Inc. wins $25 million commitment from investment firm Socius Capital Group. Advanced Cell Technology Inc. (OTC:ACTC) secured a $25 million investment to support clinical ...